LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

BioResearch

Customized Diagnostics Center Designed for Cancer Treatment, New Drug Research

A new center for personalized diagnostics is providing detailed insights into each patient’s tumor with next-generation DNA sequencing. More...
30 Apr 2013
Image: Dr. Guillaume Lessene (above) and his collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients (Photo courtesy of Walter and Eliza Hall Institute, Australia).

Novel Anticancer Drug Restores Tumor Cell Apoptotic Pathways

Cancer researchers have developed a drug that blocks a prosurvival gene in cancer cells and renders them vulnerable to elimination from the body by classical cell death pathways. More...
29 Apr 2013

Antiangiogenic Monoclonal Antibody Slows Tumor Growth in Breast Cancer and Angiosarcoma Models

A monoclonal antibody specific for a protein linked to the angiogenesis required for tumor growth was shown to have potent antitumor and antiangiogenic properties both in vitro and in mouse xenograft models. More...
29 Apr 2013

Supercomputer Offers Advanced Algorithms to Develop Predictive Models of Disease

After one year of operation, a USD 3 million supercomputer is a large step forward in constructing a substantial computational and data-intensive infrastructure designed specifically for genomics. More...
29 Apr 2013

US Pharma CEO Compensation Double That of Europeans

A new report has found that the CEOs of European pharmaceutical companies continue to receive far less than their US counterparts. More...
29 Apr 2013

"Transparent Brain" Expected to Yield Breakthroughs in Understanding Neurological Disorders

Replacement of the brain's fat content with a clear, permeable gel allows optical, fluorescent, and electron microscope studies as well as immunohistochemical analyses to be carried out on intact tissues. More...
25 Apr 2013

Loss of Beta-Cell EPAC2A Activity Linked to Development of Type II Diabetes

Diabetes researchers have discovered how the protein EPAC2A affects glucose metabolism and how loss of this protein activity may contribute to the development of type II diabetes. More...
25 Apr 2013
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automatic CLIA Analyzer
Shine i6000
New
Immunofluorescence Analyzer
IFA System


BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.
INTEGRA BIOSCIENCES AG